REVERBA GLOBAL
LIVE

Serial Number

98765445

Owner

HPG, LLC

Attorney

Robert C. Cumbow

Filing Date

Sep 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

REVERBA GLOBAL Trademark

Serial Number: 98765445

REVERBA GLOBAL is a trademark filed by HPG, LLC on September 23, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

HPG, LLC (13 trademarks)

701 Pike Street, Suite 2000
Seattle, WA 98101

Entity Type: 16

Trademark Details

Filing Date

September 23, 2024

Registration Date

Not Registered

Published for Opposition

June 10, 2025

Goods & Services

Promoting public awareness of the need for voluntary advocates to work with health-related companies and organizations to advance human health and healthcare by means of public advocacy; Public relations; Consulting services relating to publicity; Consulting services related to promoting public awareness of publicizing medical patients' personal stories on the subjects of health, illness, medical conditions, treatment, medical procedures, illness recovery and survival by means of public advocacy

Software as a service (SAAS) services featuring software for managing data and communications related to public awareness of the need for voluntary advocates to work with health-related companies and organizations to advance human health and health care

Training materials in the nature of downloadable educational media, namely, text files, audio files, video recordings, and multimedia files featuring information for biotechnology, device, and pharmaceutical companies to use in training

Training services, namely, vocational training services for physicians in the field of clinical trial conduct, approaches to disease management, and on the use of pharmaceutical products; conducting of educational conferences for pharmaceutical companies in the field of obtaining guidance on the potential role for drugs in various stages of clinical development; vocational training services for pharmaceutical company representatives in the field of disease understanding and disease management; Providing online training in the nature of courses, seminars, workshops for biotechnology, device, and pharmaceutical companies in the field of disease, treatments, patient care and counseling, and clinical trial implementation

Printed manuals in the field of training materials for pharmaceutical companies to use in training

Providing a website via a global computer network featuring supportive personal stories on the subjects of health, illness, medical conditions, treatment, medical procedures, and illness recovery and survival; Online social networking services in the field of sharing personal health and illness stories with other users provided via a website; Online social networking services provided through a community website

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 7, 2026 EXRA
SOU EXTENSION 1 GRANTED
Apr 7, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 6, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 6, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 7, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 10, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 10, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 4, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 12, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 12, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 12, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 12, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 12, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 2, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 2, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 2, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 31, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 30, 2025 NWOS
NEW APPLICATION ENTERED
Sep 23, 2024 NWAP